Blueshift Asset Management, LLC Pacira Bio Sciences, Inc. Transaction History

Blueshift Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$47.97 - $62.21 $321,878 - $417,429	-6,710 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$54.64 - $61.3 $309,863 - $347,632	-5,671 Reduced 45.8%	6,710 $376,000
Q2 2021 Aug 13, 2021	BUY	$59.18 - $69.99 $365,495 - $432,258	6,176 Added 99.53%	12,381 $751,000
Q1 2021 May 06, 2021	BUY	$59.31 - $78.82 $87,600 - $116,417	1,477 Added 31.24%	6,205 $435,000
Q4 2020 Feb 12, 2021	BUY	$50.47 - $66.26 $238,622 - $313,277	4,728 New	4,728 $283,000
Q3 2019 Nov 12, 2019	SELL	$35.66 - $44.99 $175,233 - $221,080	-4,914 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $179,704 - $235,724	4,914 New	4,914 $214,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.